|
MENU
-
-
Projects Under development
-
Seeking
Products and
capabilities
-
Offering
Products and
capabilities
-
Sourcing finished dosages for comparative clinical trials
-
Toll production (GMP) of R&D and clinical trial lots
-
NEWS
MAX Pharma Canada Inc.
starts using the Dun & Bradstreet's D-U-N-S®
Number (Data Universal Numbering System)
MAX Pharma Canada Inc.
receives US FDA labeler code
MAX Pharma Canada Inc.
acquires four product registrations for Canada. DIN transfer process is under
way with Health Canada
| |
|
ABOUT US
Since 2005, we cater to clients
located in Canada, the United States, Europe and around the world. Our
client base and supplier stable has grown steadily and is a tribute to
the ongoing added-value services and products we provide.
Based in the Ottawa region (Canada),
we adhere to the strictest processes in a manner which is in full support
of documentation and traceability to all that we do and commercialise. Our service
providers are selected based on their ability to deliver under the same
expectations of quality and follow-through as those we provide our clients.
Under
Construction
|

|